OPSIS THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Aug 2020)
What this means for you
This application is over — abandoned 03 Aug 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87182705
- Mark type
- Stylized text
- Filed
- 26 Sept 2016
- Published for opposition
- 02 May 2017
- Abandoned
- 03 Aug 2020
- Attorney of record
- Jason M. Hunt
Goods and services
- Class 005 — Pharmaceuticals: Cell based preparations derived from human stem cells for treatment of ocular disorders; cell based products derived from human stem cells useful for treatment of ocular disorders, namely, living tissue grafts for surgical implantation
- Class 010 — Medical apparatus: Cell based products derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation
Owner
- Opsis Therapeutics, LLC, Madison, WI, US
- Opsis Therapeutics, LLC, Madison, WI, US
Prosecution history
- 03 Aug 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Aug 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Dec 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2019 — SOU EXTENSION 5 GRANTED
- 22 Nov 2019 — SOU EXTENSION 5 FILED
- 02 Dec 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Nov 2019 — SOU TEAS EXTENSION RECEIVED
- 22 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2019 — SOU EXTENSION 4 GRANTED
- 20 May 2019 — SOU EXTENSION 4 FILED
- 20 May 2019 — SOU TEAS EXTENSION RECEIVED
- 29 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Dec 2018 — SOU EXTENSION 3 GRANTED
- 27 Dec 2018 — SOU EXTENSION 3 FILED
- 27 Dec 2018 — SOU TEAS EXTENSION RECEIVED